Drug-drug Interaction Study Between UIC201603, and UIC201604

NCT06568133 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Korea United Pharm. Inc.